INIFY Laboratories

INIFY Laboratories Quick Ratio

Quick Ratio (Acid Test) of INIFY Laboratories (INIFY.OL) as of Oct 28, 2026.

Quick Ratio

0.00

Last updated:

Quick Ratio (Acid Test) of INIFY Laboratories is 2025 0.00 . Quick Ratio (Acid Test) of INIFY Laboratories was 2024 0.00 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

INIFY Laboratories Stock analysis

What does INIFY Laboratories do? INIFY Laboratories AB generates revenue through providing cancer diagnostics via digital pathology services. The company offers two primary services: Full pathology Reports signed by INIFY's subspecialized pathologists and Whole Slide Images (WSI) with Pathology Decision Support Tool (PDST) analysis results. These services target healthcare providers and institutions requiring efficient, AI-optimized diagnostics for prostate biopsies. The firm's Solna, Sweden laboratory handles the entire sample processing chain, from logistics to reporting, leveraging AI to enhance quality and speed. INIFY's workflow is fully digital and standardized, initially focusing on prostate diagnostics. The company's service model includes both direct reporting by INIFY pathologists and WSI generation with PDST analysis, catering to clients seeking streamlined pathology solutions. This approach differentiates INIFY from traditional pathology services by integrating AI support throughout the diagnostic process. The business originates from ContextVision, indicating a foundation in digital pathology innovation. INIFY's offerings are designed to optimize response times and quality in prostate biopsy analysis, serving healthcare organizations that require advanced diagnostic tools without managing the full pathology workflow internally. INIFY Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about INIFY Laboratories stock

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) INIFY Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s INIFY Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — INIFY Laboratories

All Key Metrics — INIFY Laboratories